NeoGenomics Schedules its Third Quarter 2022 Earnings Release for November 8, 2022
Press Release
Read More
Liquid biopsy for detection of molecular residual disease and recurrence in head and neck squamous cell carcinoma
Literature
Read More
Updated follow-up data and biomarker analysis of pre-operative ipilimumab and nivolumab in locoregional advanced urothelial cancer (NABUCCO)
Literature
Read More